Frailty subgroup analysis of isatuximab with pomalidomide and dexamethasone in a UK-wide real-world cohort of relapsed myeloma patients.

Authors :: Djebbari F
Rampotas A
Vallance G
Panitsas F
Basker N
Sangha G
Salhan B
Karim F
Al-Kaisi F
Gudger A
Ngu L
Poynton M
Lam HPJ
Morgan L
Yang L
Young J
Walker M
Tsagkaraki I
Anderson L
Chauhan SR
Maddams R
Soutar R
Triantafillou M
Prideaux S
Obeidalla A
Eyre TA
Bygrave C
Kothari J
Basu S
Ramasamy K
Source :: British journal of haematology [Br J Haematol] 2023 Apr; Vol. 201 (1), pp. 162-167. Date of Electronic Publication: 2023 Jan 31.
Publication Year :: 2023

Subjects :: Humans
Dexamethasone therapeutic use
United Kingdom epidemiology
Antineoplastic Combined Chemotherapy Protocols therapeutic use
Neoplasm Recurrence, Local drug therapy
Multiple Myeloma drug therapy
Frailty

Full Text Access

Tools